!

COVID-19 Response 

Access our COVID-19 Response homepage, with more information and resources during the COVID-19 pandemic, including what to do if you’re experiencing symptoms.

Research

Publications

Master
Content

Calarge CA, Devaraj S, Shulman RJ. Gut permeability and depressive symptom severity in unmedicated adolescents. J Affect Disord. 2019 Mar 1;246:586-594. doi: 10.1016/j.jad.2018.12.077. Epub 2018 Dec 26. PubMed PMID: 30605877.

Calarge CA, Mills JA, Karaviti L, Teixeira AL, Zemel BS, Garcia JM. Selective Serotonin Reuptake Inhibitors Reduce Longitudinal Growth in Risperidone-Treated Boys. J Pediatr. 2018 Oct;201:245-251. doi: 10.1016/j.jpeds.2018.05.040. Epub 2018 Jun 27. PubMed PMID: 29958671; PubMed Central PMCID: PMC6153035.

Calarge CA, Mills JA, Ziegler EE, Schlechte JA. Calcium and Vitamin D Supplementation in Boys with Risperidone-Induced Hyperprolactinemia: A Randomized, Placebo-Controlled Pilot Study. J Child Adolesc Psychopharmacol. 2018 Mar;28(2):145-150. doi: 10.1089/cap.2017.0104. Epub 2017 Nov 7. PubMed PMID: 29112461; PubMed Central PMCID: PMC5831755.

Calarge CA, Mills JA, Janz KF, Burns TL, Schlechte JA, Coryell WH, Zemel BS. The Effect of Depression, Generalized Anxiety, and Selective Serotonin Reuptake Inhibitors on Change in Bone Metabolism in Adolescents and Emerging Adults. J Bone Miner Res. 2017 Dec;32(12):2367-2374. doi: 10.1002/jbmr.3238. Epub 2017 Sep 22. PubMed PMID: 28815738; PubMed Central PMCID: PMC5732069.

Calarge CA, Mills JA, Janz KF, Burns TL, Coryell WH, Zemel BS. Body Composition in Adolescents During Treatment With Selective Serotonin Reuptake Inhibitors. Pediatrics. 2017 Jul;140(1). doi: 10.1542/peds.2016-3943. Epub 2017 Jun 16. PubMed PMID: 28759400; PubMed Central PMCID: PMC5495528.

See a full list of publications.